Santen Pharmaceutical Co's total assets for Q1 2024 were ¥434.16B, a decrease of -0.35% from the previous quarter. JP:4536 total liabilities were ¥128.22B for the fiscal quarter, a -1.62% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.